Does MIDAZOLAM Cause Diffuse large b-cell lymphoma refractory? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Diffuse large b-cell lymphoma refractory have been filed in association with MIDAZOLAM (Midazolam). This represents 0.1% of all adverse event reports for MIDAZOLAM.
7
Reports of Diffuse large b-cell lymphoma refractory with MIDAZOLAM
0.1%
of all MIDAZOLAM reports
4
Deaths
4
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From MIDAZOLAM?
Of the 7 reports, 4 (57.1%) resulted in death, 4 (57.1%) required hospitalization.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIDAZOLAM. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does MIDAZOLAM Cause?
Drug ineffective (2,116)
Off label use (1,309)
Seizure (759)
Hypotension (695)
Toxicity to various agents (494)
Drug ineffective for unapproved indication (388)
Pyrexia (378)
Status epilepticus (369)
Product use in unapproved indication (356)
Cardiac arrest (350)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
Which MIDAZOLAM Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
MIDAZOLAM vs MIDAZOLAM\MIDAZOLAM
MIDAZOLAM vs MIDODRINE
MIDAZOLAM vs MIDOMAFETAMINE
MIDAZOLAM vs MIDOSTAURIN
MIDAZOLAM vs MIFEPRISTONE